{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:33Z","timestamp":1788178413924,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eprac.2026.08.008","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:49:58Z","timestamp":1786492198000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality of Life in Acromegaly: Results From the ACROFAST Study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-5070","authenticated-orcid":false,"given":"Montserrat","family":"Marques-Pamies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sampedro-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina","family":"Biagetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gim\u00e9nez-Palop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Villar-Taibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Sim\u00f3n-Muela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Sim\u00f3-Servat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Xifra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Garc\u00eda-Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Alexandra","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Aulinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Vilarrasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Librizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Calatayud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"de Miguel Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alvarez-Escola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pic\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fajardo-Monta\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Bernab\u00e9u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Jord\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Marazuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-7195","authenticated-orcid":false,"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/cen.13331","article-title":"Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: results from a 5-years prospective study","volume":"86","author":"Kyriakakis","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib2","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-17-0041","article-title":"Management of endocrine disease: quality of life tools for the management of pituitary disease","volume":"177","author":"Webb","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/clinem\/dgae444","article-title":"Personalized medicine in Acromegaly: the ACROFAST study","volume":"110","author":"Marques-Pamies","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","article-title":"Quality of life in patients with a pituitary adenoma","volume":"6","author":"Johnson","year":"2003","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.008_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/cen.13915","article-title":"Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas","volume":"90","author":"Vega-Beyhart","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.008_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas","volume":"69","author":"Van der Klaauw","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.008_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","article-title":"Treatment of acromegaly improves quality of life, measured by AcroQol","volume":"67","author":"Paisley","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib8","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","article-title":"Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire","volume":"90","author":"Rowles","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.02214","article-title":"Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study","volume":"155","author":"Webb","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.008_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/ijem.IJEM_401_20","article-title":"Health-related quality of life in acromegaly patients: results from generic and disease-specific questionnaires","volume":"24","author":"Oliveira B de A","year":"2020","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.008_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-07-0697","article-title":"Impaired quality of life of patients with acromegaly: control of GH\/IGF-I excess improves psychological subscale appearance","volume":"158","author":"Matta","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11102-013-0533-x","article-title":"Biochemical and quality of life responses to octreotide-LAR in acromegaly","volume":"17","author":"Mangupli","year":"2014","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.008_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11102-025-01515-2","article-title":"Acromegaly facial changes analysis using last generation artificial intelligence methodology: the AcroFace system","volume":"28","author":"Rashwan","year":"2025","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.008_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","article-title":"Consensus on acromegaly therapeutic outcomes: an update","volume":"21","author":"Melmed","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12731","article-title":"Treatment of acromegaly in the era of personalized and predictive medicine","volume":"83","author":"Puig-Domingo","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.23736\/S0391-1977.18.02937-1","article-title":"Precision medicine in the treatment of acromegaly","volume":"44","author":"Puig-Domingo","year":"2019","journal-title":"Minerva Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1530\/ERC-18-0565","article-title":"Molecular profiling for acromegaly treatment: a validation study","volume":"27","author":"Puig-Domingo","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib18","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/ejendo\/lvae053","article-title":"Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion","volume":"190","author":"Biagetti","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.008_bib19","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1210\/jc.2005-0260","article-title":"Long-acting somatostatin analog therapy of acromegaly: a meta-analysis","volume":"90","author":"Freda","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11102-019-01020-3","article-title":"Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study","volume":"23","author":"Petersenn","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000375451","article-title":"Quality of life in Acromegaly","volume":"103","author":"Webb","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.008_bib22","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvag030","article-title":"Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study","volume":"10","author":"Marques-Pamies","year":"2026","journal-title":"J Endocr Soc"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.008_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.008_bib24","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.08.008_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-2-13","article-title":"Acromegaly quality of life questionnaire (AcroQoL)","volume":"2","author":"Badia","year":"2004","journal-title":"Health Qual Life Outcomes"},{"issue":"16","key":"10.1016\/j.eprac.2026.08.008_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of Acromegaly with the growth hormone\u2013receptor antagonist pegvisomant","volume":"342","author":"Trainer","year":"2000","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.008_bib27","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","article-title":"Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant","volume":"93","author":"Neggers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s11102-017-0835-5","article-title":"Development of ACRODAT\u00ae, a new software medical device to assess disease activity in patients with acromegaly","volume":"20","author":"Van der Lely","year":"2017","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12020-021-02900-0","article-title":"Acromegaly disease activity according to ACRODAT\u00ae, a cross-sectional study in Spain: ACROVAL study","volume":"75","author":"Marazuela","year":"2022","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1210\/clinem\/dgaa750","article-title":"Quality of life and its determinants in patients with treated Acromegaly: a cross-sectional nationwide study in China","volume":"106","author":"Guo","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.08.008_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2017.00040","article-title":"Predictors of quality of life in Acromegaly: no consensus on biochemical parameters","volume":"8","author":"Geraedts","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/clinem\/dgaa868","article-title":"Improvement in symptoms and health-related quality of life in acromegaly patients: a systematic review and meta-analysis","volume":"106","author":"Broersen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s41687-022-00537-9","article-title":"Associations between paraclinical parameters, symptoms and quality of life in patients with acromegaly: a cross sectional study","volume":"6","author":"Gliga","year":"2022","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.008_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11102-016-0761-y","article-title":"Update on quality of life in patients with acromegaly","volume":"20","author":"Crespo","year":"2017","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.008_bib35","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","article-title":"Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.08.008_bib36","volume":"15","author":"Badia","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.eprac.2026.08.008_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1586\/erp.11.12","article-title":"Interpreting patient-reported outcome results: US FDA guidance and emerging methods","volume":"11","author":"McLeod","year":"2011","journal-title":"Experts Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.008_bib38","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0545","article-title":"Quality of life and psychological status in people with acromegaly in relation to facial changes","volume":"14","author":"Mart\u00ednez-Mombl\u00e1n","year":"2025","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.008_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.229","article-title":"Differences in quality of life between genders in acromegaly","volume":"4","author":"Ballesteros-Herrera","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.008_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","article-title":"Diagnostic delay is associated with psychosocial impairment in acromegaly","volume":"16","author":"Siegel","year":"2013","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.008_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-18-0925","article-title":"Patients\u2019 perspectives on acromegaly diagnostic delay: a qualitative study","volume":"180","author":"Sibeoni","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2026.08.008_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1516899","article-title":"Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly","volume":"16","author":"Gandhi","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.008_bib43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11102-022-01224-0","article-title":"Quality of life after long-term biochemical control of acromegaly","volume":"25","author":"Kimball","year":"2022","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.008_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ecl.2022.04.004","article-title":"Evaluating the impact of Acromegaly on quality of life","volume":"51","author":"Coopmans","year":"2022","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.008_bib45","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s40618-022-01782-x","article-title":"Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management","volume":"45","author":"Camerini","year":"2022","journal-title":"J Endocrinol Invest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:14:25Z","timestamp":1788174865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S1530891X26011080"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Acromegaly: Results From the ACROFAST Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}